预定位技术在肿瘤治疗中的应用
被引量:1
Application of technology pretarget in tumor
摘要
预定位技术是在放射免疫治疗基础上发展起来的一种新的肿瘤治疗方法 ,具有与靶抗原亲和力高、毒性低、血清清除快等优点 ,对于实体瘤有很好的疗效。目前的预定位技术主要有生物素和亲合素的预定位模式和双特异性抗体的预定位模式两种。现综述预定位技术的产生、现状及展望。
出处
《国外医学(肿瘤学分册)》
2004年第7期511-513,共3页
Foreign Medical Sciences (Cancer Section)
参考文献14
-
1Juweid ME. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice. J Nucl Med,2002,43(11): 1507-1529.
-
2Grana C,Chinol M,Robertson C, et al. Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study. Br J Cancer, 2002,86(2) :207-212.
-
3Axworthy DB,Reno JM,Hylarides MD,et al. Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. Proc Natl Acad Sci USA, 2000,97(4): 1802-1807.
-
4Breitz HB,Weiden PL, Beaumier PL, et al. Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin. J Nucl Med, 2000,41 (1): 131-140.
-
5Press OW, Corcoran M, Subbiah K, et al. A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts. Blood, 2001,98(8) :2535-2543.
-
6Weiden PL, Breitz HB, Press O, et al. Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase Ⅰ/Ⅱ study results. Cancer Biother Radiopharm, 2000,15(1) :15-29.
-
7Zhang M, Zhang Z, Garmestani K, et al. Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effctive in therapy of leukemia/lymphoma xenografts. Proc Natl Acad Sci USA, 2003,100(4): 1891-1895.
-
8Graves SS, Dearstyne E, Lin Y, et al. Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy. Clin Cancer Res, 2003, 9( 10Pt 1) :3712-3721.
-
9Wilbur DS,Hamlin DK,Chyan MK,et al. Biotin reagents for antibody pretargeting. 5. Additional studies of biotin conjugate design to provide biotinidase stability. Bioconjug Chem, 2001,12(4) :616-623.
-
10Goshom S, Sanderson J,Axworthy D, et al. Preclinical evaluation of a humanized NR-LU-10 antibody-streptavidin fusion protein for pretargeted cancer therapy. Cancer Biother Radiopharm, 2001,16(2): 109-123.
同被引文献30
-
1叶靖,许乙凯.生物素/亲和素系统用于活体分子成像现状[J].国外医学(临床放射学分册),2005,28(4):193-195. 被引量:1
-
2Goodwin D A,Meares C F,McCall M J,et al. Pretargeted immunoscintigraphy with chimeric antibodies [ J ]. J Nucl Med, 1987,28: 561.
-
3Boerman O C,Van Schaijk F G, Oyen W J G, et al. Pretargeted radioimmunotherapy of cancer: progress step by step [ J ]. J Nucl Med ,2003,44:400-411.
-
4Goodwin D A, Meares C F. Pretargeted peptide imaging and therapy [ J ]. Cancer Biother Radiopharm, 1999,14 : 145-152.
-
5Goldenberg D M. Targeted therapy of cancer with radiolabeled antibodies[J]. J Nucl Med,2002 ,43 :693-713.
-
6Rosebrough S F, Hartley D F. Biochemical modification of streptavidin and avidin: in vitro and in vivo analysis [J]. J Nucl Med,1996, 37(8) :1380-1384.
-
7Sharkey R M, Karacay H, Cardillo T M, et al. Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods[ J ]. Clin Cancer Res ,2005,11:7109s-7121 s.
-
8Hnatowieh D J, Virzi F, Rusekowski M. Investigation of avidin and biotin for imaging applications[ J ]. J Nucl Med, 1987,28 (8) :1294- 1302.
-
9Zhang M,Zhang Z,Garmestani K,et at. Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xeuografts[ J ]. Proc Natl Acad Sci USA ,2003,100(4) : 1891-1895.
-
10Graves S S, Dearstyne E, Lin Y, et al. Combination therapy with pretarget CCA9 radioimmunotherapy and gerncitabine prolongs tumor doubling timein amurine xenograftmod elofcolon cancermore effectively than either monotherapy [ J ]. Clin Cancer Res, 2003,9 (10) : 3712-3721.
二级引证文献4
-
1景滢滢,杨宇,王静,杨永莉,孙肖红,胡孔新,王振东.检测土拉弗朗西斯菌的生物素—亲和素ELISA法的建立[J].中国国境卫生检疫杂志,2010,33(4):217-220. 被引量:1
-
2邓新荣,杜进,翟士桢,沈亦佳,罗志福.奥曲肽-葡聚糖-亲和素的偶联及其与^(177)Lu-DTPA-BIS-BIOTIN的体外结合[J].同位素,2011,24(3):146-150.
-
3李传刚,李咏兰,韩志刚.免疫磁珠的制备及其在捕获乳腺癌患者白细胞中的应用[J].内蒙古师范大学学报(自然科学汉文版),2014,43(1):60-65. 被引量:1
-
4王云超,牛海涛,李凯,门同义,梁晔,张勇,张晓明,杨吉伟,沈彬,李现铎,陈冬冬,唐冠宝,王建宁.微流控芯片特异性筛选膀胱癌循环肿瘤细胞的研究[J].中华泌尿外科杂志,2016,37(12):936-939. 被引量:4
-
1樊孝廉,蒋宁一.预定位技术肺癌放射免疫显像研究的综述[J].湖北民族学院学报(医学版),2000,17(3):35-38.
-
2李贵平,彭武和.亲和素-生物素系统预定位技术在炎症显像中的应用[J].现代临床医学生物工程学杂志,2001,7(4):313-314.
-
3郑曙峰.海军疗养工作现状及展望[J].海军医学杂志,1999,17(2):175-177.
-
4陈君坤.江苏医学影像现状及展望[J].医学研究生学报,2000,13(2):72-74.
-
5邓新荣,杜进,罗志福.生物素-亲和素预定位技术在肿瘤诊断和治疗中的应用[J].标记免疫分析与临床,2010,17(1):57-59. 被引量:4
-
6于晓明,樊飞跃.肿瘤放射免疫疗法研究进展[J].国际放射医学核医学杂志,2006,30(2):80-83. 被引量:7
-
7张旭初.炎症显像中的三步预定位法[J].国外医学(放射医学核医学分册),2002,26(3):121-121.
-
8郑文莉,李贵平.亲和素-生物素系统预定位放免治疗白血病的研究[J].放射免疫学杂志,2013,26(4):428-432. 被引量:2
-
9王红,陈卓颐,王丹,曾德昕.下腰痛防治座椅研究的现状及展望[J].长沙民政职业技术学院学报,2011,18(2):117-119. 被引量:2
-
10查韡光,李安民,傅相平.胶质瘤放射免疫治疗的研究现状[J].中国微侵袭神经外科杂志,2006,11(10):474-477.